Pediatrician's Beliefs and Practices Around Rapid Infant Weight Gain: A Qualitative Study

Megan H Pesch1, Kimberley J Levitt1, Phoebe Danziger1

  • 1University of Michigan, Ann Arbor, MI, USA.

Global Pediatric Health
|February 22, 2021
PubMed

Insights

Pediatricians lack clarity on rapid infant weight gain, its definition, and management. Further training is needed to address this knowledge gap and improve infant obesity prevention strategies.

Area of Science:

  • Pediatrics
  • Public Health
  • Childhood Obesity

Background:

  • Rapid infant weight gain is a significant risk factor for developing obesity later in life.
  • Understanding healthcare providers' perspectives is crucial for effective intervention strategies.

Purpose of the Study:

  • To investigate primary care pediatricians' beliefs and practices concerning rapid infant weight gain.
  • To identify knowledge gaps and challenges in managing infant growth patterns.

Main Methods:

  • A qualitative study involving semi-structured interviews with 16 primary care pediatricians.
  • Grounded theory and constant comparative method were used for thematic analysis of interview transcripts.

Main Results:

  • All pediatricians (100%) expressed uncertainty regarding the concept, definition, and implications of rapid infant weight gain.
  • A majority (62.5%) felt more comfortable managing inadequate weight gain compared to excessive gain.
  • Most pediatricians (62.5%) identified overfeeding as the primary cause of rapid infant weight gain.

Conclusions:

  • Pediatricians demonstrate uncertainty about the definition, management, and long-term risks associated with rapid infant weight gain.
  • There is a need for targeted interventions to enhance pediatricians' awareness and competence in addressing rapid infant weight gain.
  • Improved understanding and management of infant growth are essential for early obesity prevention.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
100
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
120
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
102
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
100
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
89
Regression Toward the Mean01:52

Regression Toward the Mean

Regression toward the mean (“RTM”) is a phenomenon in which extremely high or low values—for example, and individual’s blood pressure at a particular moment—appear closer to a group’s average upon remeasuring. Although this statistical peculiarity is the result of random error and chance, it has been problematic across various medical, scientific, financial and psychological applications. In particular, RTM, if not taken into account, can interfere when...
6.6K